JP2025118607A5 - - Google Patents
Info
- Publication number
- JP2025118607A5 JP2025118607A5 JP2025060888A JP2025060888A JP2025118607A5 JP 2025118607 A5 JP2025118607 A5 JP 2025118607A5 JP 2025060888 A JP2025060888 A JP 2025060888A JP 2025060888 A JP2025060888 A JP 2025060888A JP 2025118607 A5 JP2025118607 A5 JP 2025118607A5
- Authority
- JP
- Japan
- Prior art keywords
- release formulation
- sustained release
- polypeptide
- sustained
- item
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (8)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201962837978P | 2019-04-24 | 2019-04-24 | |
| US62/837,978 | 2019-04-24 | ||
| US201962947183P | 2019-12-12 | 2019-12-12 | |
| US201962947188P | 2019-12-12 | 2019-12-12 | |
| US62/947,183 | 2019-12-12 | ||
| US62/947,188 | 2019-12-12 | ||
| JP2021562971A JP7726791B2 (ja) | 2019-04-24 | 2020-04-24 | 補体活性を調節するための組成物及び方法 |
| PCT/US2020/029733 WO2020219822A1 (en) | 2019-04-24 | 2020-04-24 | Compositions and methods for modulating complement activity |
Related Parent Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2021562971A Division JP7726791B2 (ja) | 2019-04-24 | 2020-04-24 | 補体活性を調節するための組成物及び方法 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2025118607A JP2025118607A (ja) | 2025-08-13 |
| JP2025118607A5 true JP2025118607A5 (https=) | 2025-11-11 |
Family
ID=70977557
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2021562971A Active JP7726791B2 (ja) | 2019-04-24 | 2020-04-24 | 補体活性を調節するための組成物及び方法 |
| JP2025060888A Pending JP2025118607A (ja) | 2019-04-24 | 2025-04-02 | 補体活性を調節するための組成物及び方法 |
Family Applications Before (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2021562971A Active JP7726791B2 (ja) | 2019-04-24 | 2020-04-24 | 補体活性を調節するための組成物及び方法 |
Country Status (13)
| Country | Link |
|---|---|
| US (1) | US20220211799A1 (https=) |
| EP (1) | EP3958842A1 (https=) |
| JP (2) | JP7726791B2 (https=) |
| KR (1) | KR20220004039A (https=) |
| CN (1) | CN113710230A (https=) |
| AU (1) | AU2020261059A1 (https=) |
| BR (1) | BR112021017820A2 (https=) |
| CA (1) | CA3137895A1 (https=) |
| IL (1) | IL287079A (https=) |
| MX (1) | MX2021013010A (https=) |
| SG (1) | SG11202109837SA (https=) |
| TW (1) | TW202106290A (https=) |
| WO (1) | WO2020219822A1 (https=) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU2015274482B2 (en) | 2014-06-12 | 2018-11-08 | Ucb Holdings, Inc. | Modulation of complement activity |
| EP3250230B9 (en) | 2015-01-28 | 2022-02-23 | RA Pharmaceuticals, Inc. | Modulators of complement activity |
| ES2941640T3 (es) | 2015-12-16 | 2023-05-24 | Ra Pharmaceuticals Inc | Moduladores de la actividad del complemento |
| MX2019006527A (es) | 2016-12-07 | 2019-08-01 | Ra Pharmaceuticals Inc | Moduladores de la actividad del complemento. |
| KR20210080390A (ko) * | 2018-10-22 | 2021-06-30 | 라 파마슈티컬스 인코포레이티드 | 질루코플란을 이용한 신경 질환 치료 |
| CN113966224A (zh) | 2019-06-04 | 2022-01-21 | Ra制药公司 | 采用补体抑制剂的炎性疾病治疗 |
Family Cites Families (38)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1241139A (zh) * | 1996-12-20 | 2000-01-12 | 武田药品工业株式会社 | 生产缓释制剂的方法 |
| WO2000021559A2 (en) | 1998-10-09 | 2000-04-20 | Musc Foundation For Research Development | Blocking factor b to treat complement-mediated immune disease |
| US8329169B2 (en) | 2003-05-15 | 2012-12-11 | Genentech, Inc. | Methods and compositions for the prevention and treatment of sepsis |
| CN1289066C (zh) * | 2003-09-18 | 2006-12-13 | 中国人民解放军第二军医大学 | 胰高血糖素样肽－1缓释微球制剂及其用途 |
| CA2610502A1 (en) | 2005-03-29 | 2006-10-05 | Cardax Pharmaceuticals, Inc. | Reduction in complement activation and inflammation during tissue injury by carotenoids, carotenoid analogs, or derivatives thereof |
| CA2610340C (en) | 2005-05-26 | 2016-02-16 | Vernon Michael Holers | Inhibition of the alternative complement pathway for treatment of traumatic brain injury, spinal cord injury and related conditions |
| MX2008004094A (es) | 2005-09-27 | 2009-02-27 | Efrat Biopolymers Ltd | Composiciones de polimero inyectables hidrofobicas, gelificantes. |
| EP3299027A1 (en) | 2005-11-04 | 2018-03-28 | Genentech, Inc. | Use of complement pathway inhibitors to treat ocular diseases |
| CN101341254A (zh) * | 2005-12-24 | 2009-01-07 | 蒂加斯克乳制品研究中心 | 反-10，顺-12十八碳二烯酸的生产方法 |
| US20090028832A1 (en) * | 2006-08-10 | 2009-01-29 | Chung Leland F | Compositions and methods for targeted tumor therapy |
| LT3028716T (lt) | 2006-10-10 | 2020-12-10 | Regenesance B.V. | Komplemento slopinimas nervų regeneracijos pagerinimui |
| US7736860B2 (en) | 2006-11-09 | 2010-06-15 | Univeristy Of Massachusetts | Methods of identifying compounds for the treatment of sterile inflammation |
| US20100015139A1 (en) | 2008-07-10 | 2010-01-21 | Rekha Bansal | METHOD OF INHIBITING COMPLEMENT ACTIVATION WITH FACTOR Ba SPECIFIC ANTIBODIES AND USE THEREOF |
| US20080269318A1 (en) | 2007-04-30 | 2008-10-30 | Carmelo Romano | Treatment of age-related macular degeneration using inhibitors of complement factor d |
| BRPI0812767A2 (pt) | 2007-06-07 | 2014-12-02 | Genentech Inc | Anticorpos para c3b e métodos para prevenção e tratamento de distúrbios associados ao complemento |
| WO2009014633A1 (en) | 2007-07-20 | 2009-01-29 | Trustees Of The University Of Pennsylvania | Method of treating acute respiratory distress syndrome |
| JP5473925B2 (ja) | 2007-10-27 | 2014-04-16 | コーデン ファーマ コロラド インコーポレイテッド | 固相および溶液相の組み合わせ技法を使用するインスリン分泌性ペプチドの合成 |
| WO2010025510A1 (en) | 2008-09-03 | 2010-03-11 | Xenome Ltd | Libraries of peptide conjugates and methods for making them |
| US20100086596A1 (en) * | 2008-10-06 | 2010-04-08 | Oakwood Laboratories LLC | Microspheres for releasing an octreotide compound without an initial time lag |
| LT2894165T (lt) | 2008-11-10 | 2023-03-10 | Alexion Pharmaceuticals, Inc. | Būdai ir kompozicijos, skirti su komplementu susijusių sutrikimų gydymui |
| CN102781471B (zh) | 2009-10-16 | 2016-10-12 | 奥默罗斯公司 | 通过抑制masp-2依赖性补体活化治疗弥散性血管内凝血的方法 |
| WO2011106635A1 (en) | 2010-02-25 | 2011-09-01 | The Trustees Of The University Of Pennsylvania | Treatment of sepsis using complement inhibitors |
| EP2563359A1 (en) | 2010-04-30 | 2013-03-06 | Allergan, Inc. | Novel treatment for age related macular degeneration and ocular ischemic disease associated with complement activation by targeting 5-lipoxygenase |
| TW201241008A (en) * | 2010-10-01 | 2012-10-16 | Alexion Pharma Inc | Polypeptides that bind to human complement component C5 |
| KR101870915B1 (ko) | 2011-04-08 | 2018-06-25 | 유니버시티 오브 레스터 | Ｍａｓｐ-2 의존적 보체 활성화와 관련된 질병을 치료하는 방법 |
| WO2012162215A1 (en) | 2011-05-20 | 2012-11-29 | The Trustees Of The University Of Pennsylvania | Promotion of fracture healing using complement inhibitors |
| WO2012174055A1 (en) | 2011-06-13 | 2012-12-20 | The Trustees Of The University Of Pennsylvania | Wound healing using complement inhibitors |
| US20130246083A1 (en) | 2012-03-16 | 2013-09-19 | Alexion Pharmaceuticals, Inc. | Methods of distributing complement-inhibiting drugs to patients receiving a complement inhibitor |
| US9579360B2 (en) | 2012-06-20 | 2017-02-28 | The Trustees Of The University Of Pennsylvania | Methods of treating or preventing periodontitis and diseases associated with periodontitis |
| US20130345257A1 (en) | 2012-06-26 | 2013-12-26 | The Regents Of The University Of California | Composition for lupus nephritis and methods of making and using the same |
| WO2014078622A1 (en) | 2012-11-15 | 2014-05-22 | The Brigham And Women's Hospital, Inc. | Method and system for diagnosing and treating preeclampsia |
| US20140234275A1 (en) | 2013-02-15 | 2014-08-21 | Jason Williams | Method for treating als via the increased production of factor h |
| US20160324798A1 (en) * | 2013-12-31 | 2016-11-10 | Heron Therapeutics, Inc. | Polymer-based compositions for extended release of proteins |
| AU2015274482B2 (en) * | 2014-06-12 | 2018-11-08 | Ucb Holdings, Inc. | Modulation of complement activity |
| WO2016138520A1 (en) | 2015-02-27 | 2016-09-01 | The Johns Hopkins University | Assay to diagnose and treat disorders of the alternative pathway of complement activation |
| ES2941640T3 (es) | 2015-12-16 | 2023-05-24 | Ra Pharmaceuticals Inc | Moduladores de la actividad del complemento |
| MX2019006527A (es) | 2016-12-07 | 2019-08-01 | Ra Pharmaceuticals Inc | Moduladores de la actividad del complemento. |
| TWI826364B (zh) * | 2017-04-03 | 2023-12-21 | 德商因夫萊亞斯有限公司 | 活性抑制劑於發炎性疾病之治療 |
-
2020
- 2020-04-24 BR BR112021017820A patent/BR112021017820A2/pt not_active Application Discontinuation
- 2020-04-24 JP JP2021562971A patent/JP7726791B2/ja active Active
- 2020-04-24 SG SG11202109837S patent/SG11202109837SA/en unknown
- 2020-04-24 US US17/605,495 patent/US20220211799A1/en active Pending
- 2020-04-24 MX MX2021013010A patent/MX2021013010A/es unknown
- 2020-04-24 KR KR1020217034548A patent/KR20220004039A/ko not_active Withdrawn
- 2020-04-24 EP EP20730497.3A patent/EP3958842A1/en active Pending
- 2020-04-24 TW TW109113822A patent/TW202106290A/zh unknown
- 2020-04-24 CN CN202080030772.3A patent/CN113710230A/zh active Pending
- 2020-04-24 AU AU2020261059A patent/AU2020261059A1/en not_active Abandoned
- 2020-04-24 CA CA3137895A patent/CA3137895A1/en active Pending
- 2020-04-24 WO PCT/US2020/029733 patent/WO2020219822A1/en not_active Ceased
-
2021
- 2021-10-07 IL IL287079A patent/IL287079A/en unknown
-
2025
- 2025-04-02 JP JP2025060888A patent/JP2025118607A/ja active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2025118607A5 (https=) | ||
| AU2003238862B2 (en) | Formulations for amylin agonist peptides | |
| TWI241911B (en) | Sustained release ranolazine formulations | |
| JP2637981B2 (ja) | 吸収制御薬剤組成物 | |
| KR102662530B1 (ko) | 양극성 용매에서 안정한 치료 제형들의 제조방법. | |
| WO2006105501A2 (en) | Control of blood glucose in diabetes treatment using pulmonarily administered insulin in combination with basal insulin | |
| WO2003103637A2 (en) | Modified release, multiple unit drug delivery systems | |
| CZ234898A3 (cs) | Zdokonalené koncentrované injekční a infusní roztoky pro intravazální použití | |
| MX2008016254A (es) | Uso de agonistas del receptor de adenosina a2a en el tratamiento de isquemia. | |
| CN102138912A (zh) | 硝苯地平渗透泵控释片及其制备工艺 | |
| JP2017534604A5 (https=) | ||
| CN113018277A (zh) | 注射用缓释制剂及其制备方法 | |
| KR101409330B1 (ko) | 복용순응도가 향상된 서방성 당뇨병 치료용 복합제제 및 이의 제조방법 | |
| Galanello | Iron chelation: new therapies | |
| CN1969814B (zh) | 褪黑素鼻腔给药制剂 | |
| US20170312297A1 (en) | Long Acting Pharmaceutical Compositions For Hepatitis C | |
| JPWO2020219822A5 (https=) | ||
| JP7518149B2 (ja) | 高濃度インスリン製剤 | |
| KR20250103637A (ko) | 비양성자성 극성 용매를 사용한 서방형 주사용 제형 | |
| EP1364650A1 (en) | Medicinal composition | |
| CA2685214A1 (en) | Improved controlled release oral dosage form | |
| RU2678324C2 (ru) | Составы лоразепама с замедленным высвобождением | |
| RU2471478C1 (ru) | Фармацевтическая композиция для лечения алкоголизма, наркомании и токсикомании с улучшенным профилем высвобождения налтрексона | |
| EP2409701B1 (en) | Prasugrel granules with improved stability | |
| JPH03505447A (ja) | アミオダロンと、ニトロ誘導体、特にイソソルビト二硝酸と、必要に応じてさらにβ―遮断薬とを含む心臓保護効果のある医薬組成物 |